Market Research Blog

[332 Pages Report] According to a recent study by Future Market Insights (FMI), the global acetaminophen market is expected to grow from US$ 9.4 Bn in 2021, to over US$ 14.1 Bn by 2031, expanding at a 4.1% CAGR over the forecast period 2021-2031.

During the assessment period, the global Infertility Treatment Market Share is expected to expand at a robust CAGR of 8%, from US$ 1.5 Bn in 2021 to US$ 3.5 Bn in 2032.

As per the infertility treatment market report, factors such as a decrease in global fertility rates, increased adoption of various infertility procedures, an increase in the number of fertility clinics worldwide, an increase in public and private investments, and the presence of advanced infertility treatment products in the market are expected to boost the demand for fertility services.

Physical inactivity, a continued move toward a sedentary lifestyle, improper fetal care, deferred pregnancy, smoking, excessive alcohol consumption, stress, and other factors have all contributed to an increase in the number of infertility cases.

Furthermore, an increase in the incidence of diabetes and obesity is a significant factor contributing to the rise in these illnesses’ rates. The worldwide infertility treatment market is driven by an increase in the number of fertility clinics around the world and advancements in technology to treat infertility in both men and women.

In addition, increased governmental and private sector investments in the health care industry have created a favorable infertility treatment market outlook for expansion.

A significant increase in reproductive clinics has occurred, despite a global fall in fertility rates. Along with this, the increased focus of players and governments on opening and acquiring additional fertility facilities around the world is expected to contribute to the segment’s rise. In addition, the proliferation of fertility clinics equipped with innovative technologies is expected to expand infertile couples’ access to infertility treatment options.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14317

However, in the coming years, the high cost of operations associated with reproductive approaches, as well as other issues such as lower efficacy among elderly women, are expected to be essential restrictions on demand for infertility treatment.

The infertility treatment market key developments project that over the projection period, the hospital and surgical clinics category is expected to increase significantly. Other departments, such as neonatal critical care units, help to support hospitals. In addition, hospitals provide extensive maternity care even after the delivery of a child.

The market is expected to grow as a result of government initiatives to increase the number of multispecialty hospitals with departments that perform infertility treatment procedures like IVF, as well as the growing number of surgical centers that provide surgical procedures for the treatment of infertility.

The infertility treatment market is projected to reach US$ 2.2 Bn by 2026.

Key Takeaways

• From 2021 to 2026, the Asia Pacific infertility treatment market share is expected to grow at the fastest rate of 9.1%.
• The growth of the infertility treatment market opportunities in Asia is being aided by the development of healthcare infrastructure and development in discretionary spending, rising medical tourism in Asian countries, rising healthcare expenditure, and rising awareness among people about infertility.
• The number of patients conducting IVF cycles dropped by 90 percent during the COVID-19 pandemic. COVID-19’s spread has influenced fertility clinics, resulting in the cancellation of IVF treatments, as well as fertility decisions among couples that were considering IVF treatment before the pandemic.
• During the projected period, the equipment segment is expected to increase at the fastest rate. Due to technical improvements and the existence of well-established players with a diverse product range, this market has experienced rapid expansion, and the emerging trends in the infertility treatment market are also portraying a positive picture.

“Infertility treatment treatments are becoming more widely available, and the number of fertility clinics is expanding. Increased public and private investments, as well as technical improvements, are likely to drive market expansion in the future years.”, opines an FMI analyst.

Ask the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-14317

Competitive Landscape

Cooper Companies Inc., Vitrolife, Cook Group, Thermo Fisher Scientific, Inc., Kitazato Corporation, FUJIFILM Irvine Scientific, and Hamilton Thorne Ltd. (US) are among the prominent competitors profiled in the infertility treatment market survey.

Key Segments

By Product:

• Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyser Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
• Media & Consumables
• Accessories

By Procedure:

• Assisted Reproductive Technology
  • In Vitro Fertilization
    • Intracytoplasmic Morphologically Selected Sperm Injection
    • Gamete Donation
  • Intracytoplasmic Sperm Injection
  • Surrogacy
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
• Fertility Surgeries
  • Laparoscopy
  • Hysteriscopy
  • Varicocelectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Micrsurgical Reconstruction
    • Vasovasostomy
    • Vasoepididymostomy
• Other Infertility Treatment Procedures

By Patient Type:

• Female Infertility Treatment
• Male Infertility Treatment

By End User:

• Fertility Centre’s
• Hospitals & Cergical Clinics
• Cryobanks
• Research Institutes

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa (MEA)

Key Questions Answered in the Report

• What is the Growth Outlook for the Global Infertility Treatment Market?
• What was the Size of the Infertility Treatment Market in 2021?
• What is the Adoption Trend in the Infertility Treatment Market?
• Which Region will Dominate the Infertility Treatment Market?
• What will be the Outlook for the Infertility Treatment in 2026?

Top Related Reports Healthcare Market Insights

https://www.pbookmarking.com/story/dermatology-devices-market-global-industry-analysis-size-and-forecast-2016-to-2026-title-meta-name-description-content-dermatology-devices-market-rising-demand-for-non-invasive-dermatological-procedures-boosting-market-growth-global-industry-analysis-and-

https://www.sbookmarking.com/story/dermatology-devices-market-global-industry-analysis-size-and-forecast-2016-to-2026-title-meta-name-description-content-dermatology-devices-market-rising-demand-for-non-invasive-dermatological-procedures-boosting-market-growth-global-industry-analysis-and-

https://healthcarefmi.blogspot.com/2022/09/dermatology-devices-market-report.html

https://healthandfitness901316.blogspot.com/2022/09/dermatology-devices-market-creating.html

https://myjoye.com/blogs/773/3211/dermatology-devices-market-potential-growth-share-demand-and

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

As per the ear health market share report by Future Market Insights (FMI), the market is envisaged to move forward at a modest pace with a CAGR of 6.3% during the forecast period 2022-2032.

Technological advancements in-ear health market and hearing aid devices, such as the ability to wirelessly connect devices to smartphones, i.e., Bluetooth hearing aids, are expected to be a few vital factors boosting the ear health market growth.

As per the ear health market study, the ear health market size is projected to scale up by an increase in the number of patients experiencing noise-induced hearing loss and a shift in consumer preference for plant-based supplements.

Furthermore, the study finds that untapped emerging markets in developing countries provide lucrative ear health market opportunities for market participants, auguring well regarding the ear health market future trends.

Countries all over the world are focusing on hearing solutions, which has resulted in the implementation of a variety of initiatives aimed at raising awareness and providing free care to patients. Therefore, these can be considered as emerging trends in-ear the health market.

Governments provide subsidies, grants, and funding to help people prevent and an incentive to develop various types of hearing aids with low hearing aid prices.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14288 

For instance, the Statewide Infant Screening-Hearing (SWISH) program in New South Wales (NSW) in Australia aims to identify babies born with permanent bilateral deafness in NSW. Such initiatives are expected to increase demand for ear health devices around the world and, in turn, surge the sales of ear health products.

Ear health market opportunities could be narrowed as hearing aids for tinnitus do not always work for every patient. In addition, many of them experience side effects due to taking these supplements. It can also cause severe bleeding in people on blood thinners or have clotting problems which impede the adoption of ear health devices.

Considering the factors mentioned above, the ear health market is likely to garner a revenue of around US$ 3 Bn by 2032.

Key Takeaways:

• Behind-the-ear hearing aids are likely to dominate the market based on product type since many BTE models are Bluetooth compatible and enable better wireless connectivity, driving the market.
• Attributing to the feature of multiple program memories, digital devices are expected to expand at a significant CAGR over the forecast period by technology type. In addition, the demand for these auditory aids is expected to increase due to their added features.
• The hospital pharmacies segment is anticipated to hold a large portion of the market by distribution channel. The same can be credited to favorable health reimbursement for hearing implant surgeries and increased hearing implant penetration.
• Based on patient type, the adult segment is expected to lead the market on account of the growing geriatric population and increasing awareness of the various hearing devices, including rechargeable hearing aids and implants available in the market.

“Attributing to the high levels of noise pollution, rising prevalence of the geriatric population, as well as improvements in global market players’ distribution networks, the Asia Pacific market is expected to spike at the fastest pace during the forecast period. Furthermore, market leaders are constantly developing the best hearing aids that improve the benefits of these devices for target consumers and drive regional acceptance.” avers an FMI expert.

Competitive Landscape:Benson Hearing, Starkey, Phonak, GN Store Nord A/S, MED-EL, William Demant Holding A/S, Widex USA, Inc., Sivantos Pte LTD, and Medtronic are some of the largest hearing aid companies. William Demant, GN ReSound, Sonova, Starkey Technologies, Widex, and Sivantos are the top six companies in the market, accounting for over 90% of the total market.

Ask the Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14288 

Sonova’s dominant position in the market is primarily due to new product launches and continuous innovation, such as sales of hearing aids online. However, market players such as WS Audiology, RION Co. Ltd., Starkey, and others are expected to strengthen their positions by increasing research investments to penetrate the market by hearing aid marketing.

Manufacturing outsourcing has also emerged as a key ear health market trend for participants looking to improve or maintain their ear health market share. Owing to the superior manufacturing expertise, strong presence of hearing aid specialists, and affordable hearing aids, the hearing aid market in China and South Korea are among the top destinations for manufacturing outsourcing.

A few recent developments in the ear health market are as follows:

• GN Store Nord A/S has announced the release of ReSound Key, a comprehensive hearing aid portfolio that provides greater access to improved hearing technology around the world. This launch will assist the company in strengthening its product portfolio and catering to a larger customer base.
• Sennheiser, a company, primarily involved in the development of medical audio coupled with low hearing aid cost, was acquired by Sonova Holding AG. This strategic move will help to strengthen the company’s market position and contribute to revenue growth.

Key SegmentsBy Type:

• Ear Health Devices
• Diagnostic Devices
• Tinnitus and Ear Impairment Care Supplements
• Ear Infection Treatment Medication

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Top Related Reports Healthcare Market Insights

https://vhearts.net/post/199405_the-global-dermatology-devices-market-is-anticipated-to-grow-at-a-7-0-cagr-in-te.html#gsc.tab=0

https://www.unitymix.com/post/64618_the-global-dermatology-devices-market-is-anticipated-to-grow-at-a-7-0-cagr-in-te.html

https://bookmarksmywebs.com/dermatology-devices-market-report-overview-with-geographical-segmentation-by-revenue-with-forecast-by-2032/

https://vishaltt.onesmablog.com/Dermatology-Devices-Market-Potential-Growth-Share-Demand-And-Analysis-Of-Key-Players-Analysis-Forecasts-To-2032-52094478

https://www.directoryrail.com/preview-directory/

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

In 2021, the global hemophilia treatment market is expected to be worth approximately US$ 11.1 billion. However, with a rapidly growing hemophilia patient pool globally and advancements in hemophilia treatment approaches, overall demand for hemophilia treatment is expected to rise at a 4.8% CAGR during the forecast period, surpassing a valuation of US$ 17.92 Bn by the end of 2032.

Hemophilia therapy has improved dramatically in recent years due to the introduction of new products. In addition, several government and non-government groups are stepping forward to raise awareness of hemophilia symptoms, diagnosis, and treatment.

The high prevalence of hemophilia drives the significant need for quality hemophilia treatment. As a result, several countries are developing creative techniques to improve access to high-quality care for hemophiliacs. For example, innovative methods have been created in Germany to improve the monitoring of these and other associated disorders.

Furthermore, in recent years, awareness of the need for early-stage diagnosis and treatment and its potential impact has increased dramatically throughout European countries, driving demand for a product that would greatly simulate market income. The high prevalence of hemophilia drives the significant need for quality hemophilia treatment.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14324

The high expense of hemophilia therapy, on the other hand, may have a negative impact on market growth. According to the National Hemophilia Foundation, the average cost of hemophilia treatment is over USD 300,000 per year, which has a substantial influence on operation margins, especially in today’s capitated reimbursement environment.

The emergence of the COVID-19 pandemic slightly impacted the hemophilia treatment market negatively, owing to disruption in the global supply chain and logistics. Furthermore, the impact of the coronavirus outbreak on the industry peaked during early 2020, wherein patients suffering from such ailments were at a higher risk of suffering from coronavirus as they were more prone to infectious diseases.

Owing to these factors, the hemophilia treatment market is expected to reach US$ 16.5 Bn in 2027.

Key Takeaways:

• Hemophilia A, a disease segment accounting for around 82% of the total revenue share, dominated the market in 2021.
• In 2021, the adult patient category was worth USD 6,898 million. Hemophilia is becoming more common in the adult population.
• In 2021, the prophylaxis segment was worth USD 7,998 million. This preventive medication helps to decrease hemophilic arthropathy and disability and the need for orthopedic surgery, resulting in a better quality of life.
• During the forecast period, the injectables segment is predicted to grow at a rate of over 4.9 percent due to the effective method of drug administration.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14324

Competitive Landscape:

Some of the major key players in hemophilia treatment markets are Bayer Healthcare, Biogen, Biotest AG, CSL Behring, Ferring B.V., Genentech, Kedrion, Novo Nordisk, and Octapharma, among others.

Major important players have used advanced technologies to meet the needs of consumers and gain a substantial market share.

• Novo Nordisk received FDA approval for its biologics license application for Esperoct in February 2019. This medication is intended to reduce the frequency of bleeding episodes in children and adults with congenital factor VIII deficiency. This launch aided the corporation in introducing new items, giving it a competitive advantage.
• Valoctocogene roxaparvovec (valrox) is a novel hemophilia gene therapy treatment developed by BioMarin that eliminates all bleeds and injects blood clotting factor VIII (FVIII) in patients, is expected to get FDA clearance in 2020.

Bayer Healthcare gained FDA approval for a new prolonged half-life hemophilia treatment in August 2018. A product for patients aged 12 and up. Jivi is a rFVIII replacement therapy that has been licensed for the treatment of bleeding. This approval aided the corporation in broadening its product offering globally.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-14324

Key Segments

• Hemophilia A
• Hemophilia B

• Paediatric
• Adult

• Prophylaxis
• On Demand

• Factor Replacement Therapy
• Non-factor Replacement Therapy

• Vasopressin
• Coagulation Factor

• Injectable
• Nasal Spray

• North America
• Latin America
• Asia Pacific
• Europe
• Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Surgical Instrument Tracking System Market Share is expected to grow with a wholesome growth rate of more than 15% over the forecast period 2022-2032, finds Future Market Insights (FMI) in a recent market analysis. With the need to reduce costs and increase productivity, tracking systems are becoming more popular among healthcare providers.

The US FDA’s (Food and Drug Administration) proposed UDI (Unique Device Identification) requirements are expected to promote growth in the surgical instrument tracking systems market. According to the UDI rules, labelers (manufacturers, processors, specification formulators, re-packagers, and re-labelers) of surgical instruments are anticipated to administer immediate marking at the individual instrument degree.

The high system costs, long investment cycles, affordable restraints, and technological boundaries are expected to inhibit market growth to some extent. Also, due to the COVID-19 pandemic, there was seen a little drop in growth in the first quarter of 2021.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14251

With elective and non-elective surgeries held up, delayed, or abandoned worldwide, there was a noticeable drop in the application of surgical instrument tracking systems and consumables.

Surgical instrument tracking systems additionally lead to greater monitoring by responsible parties, while limiting medical errors, resulting in increased demand. Other major drivers for market expansion include usability of such solutions in inventory management and during the work cycle, which includes surgeries, storage, sterilization protocols, and post-surgery. As a result of this, total market sales will reach US$ 900 Mn by the ending of 2032.

Emerging economies like India and China, as well as countries in the Middle East, Latin America, and Southeast Asia, are likely to provide major growth possibilities for surgical instrument tracking systems manufacturers.

Rising healthcare costs and improving healthcare infrastructure are likely to provide growth opportunities for market players in all of these economies. The surgical instrument tracking systems market will prosper significantly as a result of this.

Key Takeaways

• In 2022, the North America surgical instruments tracking systems market is expected to account for about 38.5% of the total market.
• The surgical instruments tracking systems market in Asia Pacific is expected to register a CAGR of 19% over the projected period, owing to the region’s unexplored potential opportunities.
• The RFID surgical instruments tracking is expected to gain a lot of traction, with a CAGR of 18.4% by 2032, according to surgical instruments tracking system market forecast.
• Hospital is the dominant sector of surgical instrument tracking systems market, which is estimated to account for more than 33% of revenue by 2026.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14251

Diversification of Portfolio to Be the Key to Market Dominance

Some of the major participants in the surgical tool tracking systems market include Fortive Corporation (US), Material Management Microsystems (US), Becton, Dickinson and Company (BD) (US), Haldor Advanced Technologies (US), Getinge AB (Sweden), and STERIS (US), STANLEY Healthcare (US), Surgical Safety Scanner (US) and many others.

To get a stronger foothold in the surgical instruments tracking system market, leading companies are focusing on surgical instrument management, and employing innovative marketing strategies, technological advancements, mergers, and acquisitions.

• Steris, a seller of infection control, surgical equipment, and other hospital supplies, purchased Key Surgical for US$ 850 Mn in October 2020, expanding its geographic reach and adding complementing product lines.
• T-DOC 2000 surgical tool traceability system was created by Getinge AB and Intelligent InSites, Inc. from reprocessing to inventory and logistics to use, the solution supports the sterile supply workflow of instruments, consumables, and implants.
• Flexible 6012 and Flexible 6027 RFID tags, which enable mounting flexibility, are durable, and are IP67-rated, were released in July 2020 by Vizinex RFID(US), making them perfect for tracking a variety of assets in indoor situations.
• In May 2020, STANLEY Healthcare and CISCO linked up. STANLEY’s AeroScout Real-time Location System (RTLS) platform has been completely integrated and certified with CISCO DNA Spaces, the next-generation indoor position services platform, to give healthcare organizations enterprise-wide transparency into the location and condition of equipment and individuals.

Key Segments By Component:

• Software
• Hardware
• Services

By Technology:

• Barcode
• Radio Frequency Identification (RFID)

By End User:

• Hospital
• Public Hospital
• Private Hospital
• Other End Users

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific excluding Japan
• Middle East & Africa

Top Related Reports Healthcare Market Insights

https://london-news-community.tribeplatform.com/general/post/dermatology-devices-market-future-scenario-key-insights-top-companies-I0e4A4dXjUFdhPU

https://club.vexanium.com/post/the-global-dermatology-devices-market-is-anticipated-to-grow-at-a-7-0-cagr—6335a2abd3dbada8b56f7365

https://community.wongcw.com/blogs/197767/Dermatology-Devices-Market-Revenue-Worth-Size-Segment-by-Type-Application

https://wakelet.com/wake/W13swrbJbQGPUBXiY2Fvp

https://kaalama.org/read-blog/183188

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

DUBAI, U.A.E, Sept. 29, 2021 /PRNewswire/ — As per a recent analysis conducted by FMI, the global Infection Prevention Market Share is projected to total US$ 37.4 billion in 2021. In response to the increasing demand for sterilization equipment and protective apparel across hospitals and clinical laboratories, the market is estimated to surpass US$ 56.4 billion, expanding by 1.5X through 2031.

The market registered growth at a CAGR of 3.2% between 2016 and 2020. Growing concerns regarding sterilization and disinfection coupled with increasing focus on high degree infection prevention is driving the market. Driven by this, the infection prevention market is anticipated to expand at 4.2% CAGR during the forecast period 2021-2031.

Successive outbreaks of several infectious diseases, caused due to the pathogens such as viruses, bacteria, fungi, and other parasites have been reported since the past decade. According to a study by the Centers for Disease Control and Prevention (CDC), infectious diseases were the third most leading cause of death across the U.S., followed by diseases such as parasitic diseases (15.5 million cases), and tuberculosis (9,025 cases) in 2018.

As a result of this, the demand for effective solutions to prevent the infections and provide the measures to reduce the risk of transmission are creating lucrative sales opportunities for the market.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13950

Increasing number of surgical procedures conducted across the world is propelling the demand for sterilization equipment for disinfecting surgical tools. Driven by this, FMI has forecast that disinfectors will emerge as the most adopted infection prevention product, accounting for nearly 30% of the total sales through 2031.

“Implementation of stringent regulations, mandating the use of infection prevention products such as sanitizers, surgical masks, and others across various industries is intended at countering the spread of COVID-19. This will continue accelerating the sales of infection prevention solutions over the assessment period,” says a FMI analyst.

Key Takeaways from the Infection Prevention Market Analysis

• In North America, the U.S. is estimated to dominate the market, accounting for more than 95% of the infection prevention products sales by the end of 2021.
• The U.K. and Germany are expected to collectively account for over 40% of the sales in the Europe market in 2021, owing to the implementation of infection prevention and control programs at the health care facilities.
• China is projected to emerge as the most remunerative market in East Asia, accounting for nearly 27% of the regional revenue share in 2021.
• Favored by the improvement in medical care facilities and healthcare services, the market in India is forecast to contribute over 50% of sales in the South Asia market by 2021.
• Based on end use, the hospitals and clinics segment is anticipated to project the fastest growth, expanding at a CAGR of 3.4% through 2031.

Key Drivers

• Surging demand for industrial disinfectants and cleaners owing to increasing awareness amongst healthcare service providers across North America and Europe is spurring the sales of infection prevention products.
• Increasing demand for personal protective products such as surgical gloves and marks due to the outbreak of the novel coronavirus is pushing the protective apparel and textiles segment growth.

Key Restraints

• Implementation of stringent regulations by regulatory bodies such as the Food and Drug Administration (FDA) on the proper disposal of waste generated by disinfectants production is hampering the market growth.
• Long term usage of infection prevention products such as chemical agents and disinfectants may lead to chronic health issues such as respiratory irritation, cancer, mutagenic changes, headaches, and breath-shortening, which is, in turn, hindering the market.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/REP-GB-13950

Competitive Landscape

Key players in the global infection prevention market are adopting expansion strategies such novel product development, speedy regulatory approvals, clinical trials, acquisition, and partnerships to expand their market share and strengthen their global footprint. For instance,

• In December 2020, Getinge AB, a global medical technology company based in Sweden, announced launching a Stainless Steel DPTE® Beta Containers. The containers are designed to prevent the spread of infections by efficient loading and unloading into sterile zones.
• In February 2019, Cantel Medical Corp., innovative infection prevention manufacturers in the U.S. announced acquiring an Italian based company, Omnia S.p.A. to expand its product portfolio with surgical consumable solutions.

Leading players operating in the market profiled by FMI are:

• Cantel Medical
• Getinge AB
• STERIS
• ASP (Advanced sterilization Products)
• Sotera Health
• 3M
• Ecolab
• Halyard Worldwide, Inc. (Halyard health)
• Matachana Group
• Belimed, Inc.
• Pal International
• Reckitt Benckiser Group PLC.
• Metrex Research, LLC.
• Terumo Corporation

More Valuable Insights on Infection Prevention Market

FMI, in its new report, offers an unbiased analysis of the global infection prevention market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in infection prevention market with detailed segmentation:

By Product:

• Sterilization Equipment
  • Low Temperature Equipment
    • Ozone Sterilizers
    • Hydrogen Peroxide Sterilizers
    • Formaldehyde Sterilizers
    • Ethylene Oxide Sterilizers
    • Other Low-Temperature
  • Heat Sterilization Equipment
    • Moist Heat Sterilizers
    • Dry Heat Sterilizers
  • Radiation Sterilization Equipment
  • Liquid Sterilization Equipment
• Disinfectors
  • Washer Disinfectors
  • Endoscope Repressors
  • Flusher Disinfectors
  • Surface Disinfectants
  • Hand Sanitizers
• Consumables
  • Sterilization Supplies
    • Sterile Containers
    • Sterilization Wrap
    • Sterilization Indicators
• Protective Apparel & Textiles
  • Surgical Gloves
  • Surgical Drapes
  • Surgical Gowns
  • Surgical Masks
• Infectious Waste Disposal

By End User:

• Hospitals & Clinics
• Pharmaceutical Companies
• Clinical Laboratories
• Medical Device Companies
• Life Sciences Industries
• Academic and Research Institutes

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Key Questions Covered in the Report

• The report offers insight into infection prevention market demand outlook for the forecast period 2021-2031
• The market study also highlights projected sales growth for infection prevention market between 2021 and 2031
• Infection prevention market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
• Infection prevention market share analysis, covering key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Top Related Reports Healthcare Market Insights

https://www.spoke.com/topics/dermatology-devices-market-industry-future-set-to-massive-growth-with-high-cagr-value-by-2032-6335a1f2fc7286f9ae025e14

https://www.pressreader.com/@nickname26874564

https://www.letsdiskuss.com/post/dermatology-devices-market-future-trends-industry-size-and-forecast-to-2032

https://www.scoop.it/topic/automotive-by-vishal-58/p/4136209112/2022/09/29/dermatology-devices-market-analysis-by-size-share-growth-trends-up-to-2032?&kind=crawled&fId=1081630

https://odlook.com/post/6035_the-global-dermatology-devices-market-is-anticipated-to-grow-at-a-7-0-cagr-in-te.html

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

[312 Pages Report] According to an exclusive report of Future Market Insights, the global epilepsy monitoring devices market is expected to grow at a CAGR of 5% to US$ 838 Billion by 2032, up from US$ 490 Million in 2021.

Increasing demand for electrical stimulation to treat urinary incontinence is expected to boost the global pelvic floor stimulator market share. According to a report by Future Market Insights (FMI), the global pelvic floor stimulator market was valued at US$ 110.4 Mn in 2020 and is predicted to expand at a CAGR of over 8.8% during the forecast period (2021–2031).

Weakening of pelvic floor muscles, urinary tract infections, menopause, constipation, obesity, and alcoholism are the main causes of urinary incontinence. The rising prevalence of these conditions, added to the growing elderly population, are major drivers for the global pelvic floor stimulators market.

Similarly, a high level of portability and lower costs of mobile devices in contrast to fixed devices or surgical treatments, and progressive therapeutic results and easy access to patients through over-the-counter (OTC) medical channels are expected to drive demand.

Initiatives undertaken by government and non-governmental organizations to create awareness are increasing the demand for pelvic floor stimulators. For instance, the Australian government has started a program “National Continence Management Program.”

The government of Australia also started “The continence aids payment scheme (CAPS).” COVID-19 kicked the pelvic floor stimulators demand into high gear—and this extended to consumers increasing their adoption using online sales channels. However, lack of labor, halt on transportation, and disruptions in the supply chain, has affected device availability and growth prospects for the near future.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13187

Manufacturers are focusing on research and development activities to develop unique and technologically advanced devices with rechargeable functionality. In March 2019 InControl Medical received FDA approval for a new Attain designed for at-home use to women in the U.S. suffering from stress, urge, mixed urinary incontinence or bowel incontinence.

Key Takeaways from Pelvic Floor Stimulator Market Study

• Electrical stimulators will reflect a revenue share of more than 66% with a CAGR of 9.1% owing to the high demand for treatment research for urinary incontinence.
• Urinary Incontinence holds a share of over 75% in 2021, due to the growing geriatric population which is prone to urinary incontinence.
• The U.K and Germany are leading markets in Europe, cumulatively accounting for over 45% of the regional value share, owing to consumer reliance on technology for health information.
• Driven by a matured healthcare and research sector, the U.S., will account for more than 78% of the North America market by 2031.
• China is a high potential market reflecting a 9.9% CAGR, driven by a rapidly growing consumer demographic of geriatrics.

 “Increasing prevalence of pelvic floor disorders and subsequently rising increasing awareness about the benefits electrical stimulation in the treatment of urinary incontinence are driving the adoption pelvic floor stimulators on a global scale through 2031,” says the FMI Analyst.   

Contact our Market Research Specialist @ https://www.futuremarketinsights.com/ask-question/rep-gb-13187

Key Participant InsightsKey players in the market are focusing on strategic collaborations, acquisitions, and expansion. Furthermore, product launches, agreements and research sponsorships are key strategies adopted by manufacturers to expand their research and development capabilities, while increasing their sales by strengthening product portfolios in the pelvic floor stimulator market.

In August 2020, Medtronic expanded leadership to launch InterStim Micro Neurostimulator and InterStim SureScan MRI Leads, for treating bladder and bowel control conditions.

Want More Insights? Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels that provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global pelvic floor stimulator market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the pelvic floor stimulator market on basis of product type [Electrical stimulators and Magnetic Stimulators], application (Urinary Incontinence, Sexual Dysfunction and Neurodegenerative Diseases). Based on End User [Hospitals, Ambulatory Surgical Centers and Specialized Clinics] across seven major regions.

Pelvic Floor Stimulators Market by CategoryProduct Type:

• Electrical stimulators
• Magnetic Stimulators

Application:

• Urinary Incontinence
• Sexual Dysfunction
• Neurodegenerative Diseases

End-User:

• Hospitals
• Ambulatory Surgical Centers
• Specialized clinics
• Homecare setting

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

Top Related Reports Healthcare Market Insights

https://www.sbookmarking.com/story/diabetic-shoes-market-size-industry-share-trends-2032-title-meta-name-description-content-300-pages-report-diabetic-shoes-market-is-expected-to-reach-us-14-9-bn-and-is-likely-to-surge-at-a-vigorous-cagr-of-6-4-during-the-forecast-period-of-2022-2032-meta-

https://medium.com/@vishal.tupkar/the-global-dermatology-devices-market-is-anticipated-to-grow-at-a-7-0-d22071047d76

https://www.evernote.com/shard/s703/client/snv?noteGuid=bd217f88-4433-27a0-4d29-3ddae0917f90&noteKey=1db89851d18abf84112dc8c742d5ade0&sn=https%3A%2F%2Fwww.evernote.com%2Fshard%2Fs703%2Fsh%2Fbd217f88-4433-27a0-4d29-3ddae0917f90%2F1db89851d18abf84112dc8c742d5ade0&title=Dermatology%2BDevices%2BMarket%2BSegmentation%2BApplication%252C%2BTechnology%2B%2526%2BAnalysis%2BResearch%2BReport%2BTo%2B2032

https://www.tumblr.com/researchvishal/696735952020897792/dermatology-devices-market-value-with-status-and?source=share&_branch_match_id=1092693908979658921&_branch_referrer=H4sIAAAAAAAAAwXBUQ6EIAwFwBPVJsYvb1OhESIV0z4w7ul3pgBP7MyCBcOO5kvqxq6h4qnMGkUaZ3UT9NbPj7LOmjTIxC8FTWlD6a0oFBCMILkzX%2Fh1BN7NzvUPqTqVPmIAAAA%3D

https://www.xing.com/discover/detail-activities/6719751277.200394

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs